UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): ~~October~~November 820, 2012

Medical Care Technologies Inc.

MEDICAL CARE TECHNOLOGIES INC.

(Exact Name of Registrant as Specified in Its Charter)

Nevada

(State or Other Jurisdiction of Incorporation)

26-4227137

(I.R.S. Employer Identification Number)

000-53665

(Commission File Number)

Room 815, No. 2 Building, Beixiaojie, Dongzhimen Nei, Beijing, China

(Address of principal executive offices)

~~011~~ (8610) 6407 0580

(Issuer's telephone number)

_______

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Section 1 – Registrant’s Business and Operations

Item 1.01 Entry into a Material Definitive Agreement.

On October 8, 2012, Medical Care Technologies Inc. (the "Company") executed an Executive Officer Employment Agreement (the “Agreement”), between the Company and Thomas J. (Joe) Hall II to appoint Mr. Hall as its Chief Operating Officer. The Agreement provides for a 6-month term, renewal upon mutual agreement and the remuneration and issuance of 80,000,000 restricted shares of the Company’s common stock.

The foregoing summary of the Executive Officer Employment Agreement with Thomas J. (Joe) Hall II is not intended to be complete and is qualified in its entirety by reference to the Agreement, a copy of which is attached hereto as Exhibit 10.58 and is incorporated herein by reference. All statements made herein concerning the Agreement are qualified by reference to said Exhibit.

Section 3 – Securities and Trading Markets

Item 3.02 Unregistered Sales of Equity Securities.

The disclosure set forth above under Item 1.01 (Entry into a Material Definitive Agreement) is incorporated by reference into this Item 3.02. The issuance of the 80,000,000 shares to Thomas J. (Joe) Hall described in Item 1.01 above were issued in reliance upon an exemption from registration pursuant to Section 4(2) under the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. Mr. Hall, as Chief Operating Officer of the Company had access to information concerning the operations and financial condition of the Company, is acquiring the securities for his own account and not with a view to the distribution thereof, and is an “accredited investor” as such term is defined in Rule 501 (a) of Regulation D promulgated under the Securities Act. At the time of the issuance, the shares will be deemed to be restricted securities for purposes of the Securities Act and the certificate representing the securities shall bear legends to that effect.

On October 9, 2012, the Company issued 80,000,000 restricted shares of common stock to Thomas J. (Joe) Hall II. The issuance was in reliance upon an exemption from registration pursuant to Section 4(2) under the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 8, 2012, Mr. Luis Kuo accepted the promotion from Chief Operating Officer to President of the Company. Mr. Kuo’s predecessor, Madame Ning Wu, stepped down as President to accommodate Kuo’s appointment but maintains her role as Chief Executive Officer and will continue to serve on the Board of Directors of the Company.

Section 7 – Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.

On ~~October~~November 1220, 2012, Medical Care Technologies Inc. (“the Company”) issued a press release announcing ~~Luis~~a ~~Kuo~~CEO’s ~~transition~~Letter ~~from~~to ~~Chief~~Shareholders ~~Operating~~(“CEO’s ~~Officer~~Letter”) tofrom ~~President~~Ning C. Wu, CEO of the Company. A ~~and~~copy of the ~~appointment~~press ofrelease ~~Thomas~~incorporating J.the ~~(Joe)~~CEO’s ~~Hall~~Letter IIis tofurnished ~~its~~herewith ~~Chief~~and ~~Operating~~is ~~Officer~~incorporated by reference herein as Exhibit 99.1.

AThe ~~copy~~information ofcontained ~~this~~herein, ~~press~~including ~~release~~Exhibit is99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as ~~Exhibit~~amended ~~99.1~~(the “Exchange Act”) or otherwise subject to ~~this~~the ~~Current~~liabilities ~~Report~~of onthat ~~Form~~Section, ~~8-K~~nor ~~and~~shall isit be deemed incorporated by reference ~~into~~in ~~this~~any ~~Item~~filing 7under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.~~01.~~

Cautionary Note Regarding Forward-Looking Statements. Except for historical information contained in the press release attached as Exhibit 99.1 hereto, the press release contains forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary notes in the press release regarding these forward-looking statements.

Section 9 – Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

10.58	Executive Officer Employment Agreement dated October 8, 2012 between Medical Care Technologies Inc. and Thomas J. (Joe) Hall II
99.1	Press Release dated October 12, 2012

99.1	Press Release: CEO’s Letter to Shareholders dated November 20, 2012

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: ~~October~~November 1220, 2012

~~MEDICAL~~Medical ~~CARE~~Care ~~TECHNOLOGIES~~Technologies ~~INC~~Inc. /s/ Ning C. Wu Ning C. Wu Chief Executive Officer & Director

Filing Compare · Medical Care Technologies Inc.